Archive for: May 2007

Researchers have isolated five regions of the genome containing genes which can increase a woman's risk of developing breast cancer, reveals a major international study published online in Nature. The Cambridge based scientists led an international team of researchers in the world's first large-scale 'whole genome search' for faulty genes that increase breast cancer risk. They studied the DNA in nearly 50,000 women.

Researchers have found that men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine. In addition, red wine appears particularly protective against advanced or aggressive cancers.

Researchers have found that men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine. In addition, red wine appears particularly protective against advanced or aggressive cancers.

The most significant single predictor of aggressive prostate cancer is an elevated rate of increase in prostate specific antigen (PSA) levels, according to a new study.

The most significant single predictor of aggressive prostate cancer is an elevated rate of increase in prostate specific antigen (PSA) levels, according to a new study.

Performing less invasive laparoscopic surgery using robotic technology may improve survival rates for prostate cancer patients, according to a study by urologic oncologists. The American Cancer Society reports that one in six men will develop prostate cancer in his lifetime.

Injecting botulinum toxin A, or Botox, into the prostate gland of men with enlarged prostate, eased symptoms and improved quality of life up to a year, according to a new study. Twenty-seven out of 37 patients, or 73 percent, experienced a 30 percent improvement in urinary tract symptoms and quality of life up to one year post-injection.

Performing less invasive laparoscopic surgery using robotic technology may improve survival rates for prostate cancer patients, according to a study by urologic oncologists. The American Cancer Society reports that one in six men will develop prostate cancer in his lifetime.

Injecting botulinum toxin A, or Botox, into the prostate gland of men with enlarged prostate, eased symptoms and improved quality of life up to a year, according to a new study. Twenty-seven out of 37 patients, or 73 percent, experienced a 30 percent improvement in urinary tract symptoms and quality of life up to one year post-injection.

A minimally invasive device for treating recurrent stress urinary incontinence in women has been shown to be safe and effective in early clinical trials and is now under review by the US Food and Drug Administration (FDA), according to urologist.